Kairos Pharma (KAPA) Intangibles (2023 - 2025)
Kairos Pharma's (KAPA) quarterly Intangibles came in at $62000.0 in Q4 2025, down 72.07% YoY from $222000.0 in Q4 2024, and down 56.34% on a QoQ basis from $142000.0 in Q2 2025.
Kairos Pharma (KAPA) Intangibles (2023 - 2025) Analysis & Trends
Kairos Pharma (KAPA) has 3 years of Intangibles data on file, last reported at $62000.0 in Q4 2025.
- Quarterly Intangibles fell 72.07% year-over-year to $62000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $62000.0 (down 72.07% YoY) and the FY2025 annual result came in at $62000.0, down 72.07% from the prior year.
- Intangibles declined to $62000.0 in Q4 2025, from $142000.0 in the prior quarter.
- In the past five years, Intangibles ranged from a high of $382000.0 in Q4 2023 to a low of $62000.0 in Q4 2025.
- A 3-year average of $208666.7 and a median of $202000.0 in 2024 frame the typical range for Intangibles.
- Annual changes were most pronounced in 2024 — Intangibles plunged 41.88% — and 2025, when it sank 72.07%.
- Tracing KAPA's Intangibles over 3 years: stood at $382000.0 in 2023, then sank by 41.88% to $222000.0 in 2024, then slumped by 72.07% to $62000.0 in 2025.
- The last three Intangibles figures came in at $62000.0 (Q4 2025), $142000.0 (Q2 2025), and $182000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 60.96 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 93.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Kairos Pharma | 5.39 Mn | 55,970.58 | - | 62,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 62,000.00 |
| Jun 30, 2025 | 142,000.00 |
| Mar 31, 2025 | 182,000.00 |
| Dec 31, 2024 | 222,000.00 |
| Sep 30, 2024 | 262,000.00 |
| Dec 31, 2023 | 382,000.00 |